Symbol
| DNMT1
| contributors: shn/mct - updated : 22-12-2016
|
HGNC name
| DNA (cytosine-5-)-methyltransferase 1
|
HGNC id
| 2976
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
in telencephalic GABAergic interneurons of schizophrenia brain | tumoral
|  
|  
|  
| gain of function
|
in leukemia | constitutional
|  
|  
| --low
|  
|
by specific hypermethylation in placenta, and promoter methylation attenuates transcriptional activity in trophoblast cells | tumoral
|  
|  
| --low
|  
|
responsible for induction of DDX53 drug-resistant cancer cells | constitutional
|  
|  
|  
|  
|
affect the DNA damage response (DDR) in the cell | constitutional
|  
|  
| --over
|  
|
by hypomethylation involved in other autoimmune diseases such as lupus | |
Susceptibility
|
to autoimmune disease |
Variant & Polymorphism
SNP
| increasing the risk of autoimmune disease |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | | | |
development of novel combination therapies that will exploit DNMT1 role not only as a maintenance methyltransferase, but also as a modulator of the DNA damage response, to more efficiently target tumor cells for destruction |
| | | |
| Dnmt1 mutant mice with 90% of hypomethylated cortical and hippocampal cells in the dorsal forebrain from E13.5 on are viable but display severe neuronal cell death between E14.5 | |
conditional mutant mice lacking Dnmt1 and Dnmt3 in forebrain excitatory neurons have abnormal long-term plasticity in the hippocampal CA1 region with deficits in learning and memory |